Search the Newsreel

Blackstone, Apollo, KKR Employees Duped in Cyberattack Campaign

Employees of prominent private equity firms, including Blackstone, Apollo, and KKR, have been targeted in a cyberattack campaign. The attackers, using social engineering tactics like "vishing" and fake login pages, tricked employees into revealing their credentials and multifactor authentication codes. Google's Threat Intelligence Group …

MBX Biosciences, Inc. (MBX) stock price, news, quote and history

MBX Biosciences, Inc. (MBX) stock is currently trading at 66.65 USD, down 0.69% as of 14:23:14 GMT-4. The company is a clinical-stage biopharmaceutical firm focused on developing precision peptide therapies for endocrine and metabolic disorders, with lead candidates in Phase 3 and Phase 2 …

Hackers Target Blackstone, CME, KKR, Other Top Private Equity Firms In Ransom Campaign

Hackers are targeting major US financial and professional services firms, including Blackstone, CME Group, and KKR, in a ransomware campaign. They use social engineering tactics like fake IT calls and fraudulent websites to steal employee credentials and authentication codes. Google reported that some organizations …

Blackstone Inc. stock falls Thursday, underperforms market

Blackstone Inc. (BX) stock fell by 1.90% to $133.45 on Thursday, underperforming the broader market. This decline occurred during a generally negative trading session, with the S&P 500 Index and Dow Jones Industrial Average also experiencing losses. This marks the second consecutive day of …

MBX Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Earnings Flash (MBX) MBX Biosciences Posts Q2 Net Loss $0.78 a Share, vs. FactSet Est of $0.63 Loss

MBX Biosciences (MBX) reported a Q2 net loss of $0.78 per share, which is wider than the FactSet estimate of a $0.63 loss per share. This financial update was published on August 6, 2026, and also noted a subsequent decline in MBX Biosciences shares. …

MBX Biosciences posts Q2 loss, advances obesity pipeline By Investing.com

MBX Biosciences Inc. (NASDAQ:MBX) reported a Q2 loss of $0.78 per share, with net loss widening to $37.1 million due to increased R&D and administrative expenses. Despite the loss, the clinical-stage biopharmaceutical company made progress in its pipeline, including positive initial Phase 1 data …

Press Release: Blackstone Secured Lending Fund Reports Second-Quarter 2026 Results

This press release from Blackstone Secured Lending Fund (BXSL) announces its financial results for the second quarter of 2026. The report provides key financial metrics and operational highlights for the period.

An MBX Biosciences obesity candidate showed 7% mean weight loss in 8 weeks

MBX Biosciences reported Q2 2026 financial results and pipeline updates, highlighting preliminary Phase 1 data for its obesity candidate MBX 4291, which showed a mean weight loss of 7% at eight weeks. The company also nominated two new once-monthly obesity candidates, MBX 6180 and …

MBX Biosciences 2Q 2026: Net loss $(37.1M), EPS $(0.78) — 10-Q Summary

MBX Biosciences, Inc. reported a wider net loss in Q2 2026, totaling $(37.1M) or $(0.78) per share, compared to $(19.4M) or $(0.58) per share in the prior year. The company, which has no product revenue and is funded by equity offerings, highlighted clinical progress …

Blackstone Secured Lending Fund (NYSE: BXSL) Q2 2026 earnings snapshot

Blackstone Secured Lending Fund reported Q2 2026 results with net investment income of $174 million ($0.75 per share) and net income of $9 million ($0.04 per share). The company declared a third-quarter dividend of $0.77 per share, yielding an annualized 12.1% on NAV. The …

Blackstone Secured Lending reports over $700 million in Q2 repayments

Blackstone Secured Lending Fund (NYSE: BXSL) reported healthy second-quarter 2026 earnings, with new investment activity exceeding $300 million and repayments totaling over $700 million. The company declared a third-quarter 2026 dividend of $0.77 per share. BXSL's portfolio primarily consists of first-lien senior secured debt, …

MBX Biosciences Shares Lower After Q2 Loss Widens

MBX Biosciences (MBX) shares dropped by approximately 1.0% in Thursday trading following the announcement of its Q2 results, which reported a widened loss. The article from MT Newswires indicates that further details are available for subscribers only.

MBX Biosciences (Nasdaq: MBX) widens Q2 loss but holds $418.6M cash

MBX Biosciences (MBX) shares dropped by approximately 1.0% in Thursday trading following the announcement of its Q2 results, which reported a widened loss. The article from MT Newswires indicates that further details are available for subscribers only.

MBX Biosciences (MBX) Earnings Date and Reports 2026

Royal Bank of Canada Lowers Stock Position in BXP, Inc. $BXP

Blackstone (BX) Earnings And Dividend Lift Put Valuation Back In Focus

Blackstone Inc. (NYSE: BX) director moves 3,000 shares to controlled LLCs

Blackstone Inc. director William G. Parrett reported two "Other acquisition or disposition" transactions on August 3, 2026, transferring 3,000 shares of Common Stock. This involved moving 1,500 shares to a controlled limited liability company at a reference price of $134.68 per share. Following these …

Insider Selling: MBX Biosciences (NASDAQ:MBX) Insider Sells $24,334.90 in Stock

MBX Biosciences insider Salomon Azoulay sold 370 shares worth $24,334.90 to cover tax withholding obligations from vested equity awards, reducing his stake by 2.51%. The company's stock, NASDAQ:MBX, traded down $3.22 to $67.48 on Wednesday, though it remains near its 12-month high. Analyst sentiment …

MBX Biosciences (MBX) CMO sells 370 shares to cover RSU taxes

MBX Biosciences' Chief Medical Officer, Salomon Azoulay, sold 370 shares of common stock on August 4, 2026, at a weighted average price of $65.77 per share. This transaction was executed to cover tax obligations arising from the vesting of restricted stock units, as part …

$1.1B Loan To HPP And Blackstone In Special Servicing

A $1.1 billion loan to Hudson Pacific Properties (HPP) and Blackstone, backed by Hollywood studio properties partially leased to Netflix, has moved into special servicing ahead of its August 9 maturity date. HPP's CFO stated that terms for a longer-term extension, along with a …

Blackstone pitches $36 billion debt deal for Anthropic AI chips

Blackstone is reportedly in preliminary discussions with investors for a potential $36 billion debt financing deal to support Anthropic's consumption of Google AI chips. This new proposal, if finalized, would exceed a previous $35 billion deal involving Apollo Global Management and Blackstone for similar …

MBX Biosciences (NASDAQ:MBX) Reaches New 52-Week High - Still a Buy?

MBX Biosciences (NASDAQ:MBX) recently hit a new 52-week high, trading at $71.12 before settling at $70.70. The company maintains a "Moderate Buy" consensus rating from analysts with an average price target of $71.12. Institutional investors have also increased their holdings in MBX Biosciences during …

Blackstone Digital Infra Trust (BXDC) sits on $1.9B IPO cash

Blackstone Digital Infrastructure Trust Inc. (BXDC), a REIT focused on hyperscale data centers, completed its IPO in May 2026, raising $1.9 billion in net proceeds. As of June 30, 2026, BXDC had not yet acquired any data center assets and held almost all of …

Blackstone Digital Infrastructure Trust (BXDC) posts Q2 2026 net income

Blackstone Digital Infrastructure Trust Inc. (BXDC) reported a net income of $7.1 million, or $0.14 per share, for Q2 2026, with FFO and AFFO per adjusted share at $0.07 and $0.08 respectively. The company, which recently completed its IPO, focuses on acquiring and owning …

Price to earnings forward of ABx Group Limited – ASX:ABX

Nonprofit wants TXNM to hand $240 million to customers over ‘waived’ Blackstone termination fee

An Albuquerque nonprofit, Prosperity Works, is urging TXNM Energy Inc. to provide $240 million in rate credits to customers. This demand follows state regulators voiding a $400 million stock sale to Blackstone Inc. Prosperity Works contends that TXNM imprudently waived a $350 million termination …

Mbx Biosciences stock hits all-time high of 69.5 USD By Investing.com

MBX Biosciences stock has reached an all-time high of $69.50, reflecting a 414% total return over the past year and a 104% year-to-date surge. While analysts have revised earnings upwards, InvestingPro's Fair Value analysis suggests the stock might be slightly overvalued. The company recently …

Blackstone has pitched a mega-debt package for Anthropic chip deal - report (BX:NYSE)

Blackstone (BX) is reportedly in early discussions with investors to gauge interest in a large debt package. This financing would support Anthropic's (ANTHRO) acquisition and use of chips from Alphabet's (GOOG) (GOOGL) Google. This marks a potential second significant debt deal arranged by Blackstone …

Blackstone Gauges Interest in New Debt Package for Anthropic Chip Deal

Blackstone Inc. is reportedly gauging interest in a new debt package to help finance a chip deal between Anthropic and Google. This news follows previous reports of Blackstone gauging investor interest for a similar debt package. The move highlights Blackstone's involvement in significant financing …

Blackstone reportedly mulls second debt package for Anthropic chip deal

Blackstone Inc. is reportedly in early discussions with investors to arrange a second substantial debt package, potentially worth at least $36 billion, to fund Anthropic PBC's procurement of chips from Alphabet Inc.'s Google. This potential deal would follow a $35 billion debt package previously …

MBX Biosciences, Inc. (MBX) awards CFO 130,000 options and 28,000 RSUs

MBX Biosciences, Inc. (MBX) has awarded its Chief Financial Officer, John W. Smither, 130,000 stock options and 28,000 restricted stock units (RSUs) on August 3, 2026. The RSUs vest 25% annually from July 2027 to 2030, while the stock options, with an exercise price …

MBX Biosciences, Inc. (MBX) grants CEO major option and RSU awards

MBX Biosciences, Inc. (MBX) reported that its President and CEO, Steven L. Hoerter, received significant equity awards on August 3, 2026. These awards include stock options for 331,000 shares with an exercise price of $64.41 and 71,000 restricted stock units (RSUs). Both the options …

California State Teachers Retirement System Sells 57,483 Shares of BXP, Inc. $BXP

Arrowstreet Capital Limited Partnership Makes New $4.94 Million Investment in BXP, Inc. $BXP

New Blackstone data center trust reports $7.1M Q2 income

Blackstone Digital Infrastructure Trust (NYSE: BXDC) announced its Q2 2026 results, reporting a net income of $7.1 million and $0.14 per share. FFO and AFFO per share were $0.07 and $0.08, respectively. CEO Nick Pell expressed gratitude to investors following their recent IPO, emphasizing …